• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bionomics Ltd

+ Add to Watchlist

BNO:AU

0.4100 AUD 0.0100 2.38%

As of 22:10:42 ET on 12/23/2014.

Snapshot for Bionomics Ltd (BNO)

Open: 0.4100 Day's Range: 0.4100 - 0.4100 Volume: 51,109
Previous Close: 0.4200 52wk Range: 0.3700 - 0.8000 1-Yr Rtn: -43.84%

Stock Chart for BNO

No chart data available.
  • BNO:AU 0.4100
  • 1D
  • 1M
  • 1Y
0.4200
Interactive BNO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BNO

Current P/E Ratio (ttm) 43.6170
Estimated P/E(06/2015) 18.6364
Relative P/E vs. AS51 2.4131
Earnings Per Share (AUD) (ttm) 0.0094
Est. EPS (AUD) (06/2015) 0.0220
Est. PEG Ratio -
Market Cap (M AUD) 171.16
Shares Outstanding (M) 417.47
30 Day Average Volume 142,005
Price/Book (mrq) 3.8180
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BNO

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BNO

Bionomics Limited operates as a biotechnology company, which specializes in the genetics field. The Company, which is affiliated with a number of research institutions, seeks to develop a variety of genomic, genetic, molecular and cell biology techniques, which they believe will help demonstrate the onset and progression of diseases like epilepsy and breast cancer.

Deborah RathjenManaging Director/CEOMelanie YoungCFO/Secretary
Jose IglesiasChief Medical Officer
More Company Profile & Key Executives for BNO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil